16th Sep 2008 07:00
|
Press Release |
16 September 2008 |
Surgical Innovations™ Group plc
("SI" or "the Group")
Notice of Results
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, advises that it will be announcing its Interim Results for the six months ended 30 June 2008 on Monday 29 September 2008.
An analyst briefing will be given by Doug Liversidge (Non-Executive Chairman) and Graham Bowland (Managing Director) at 09.30 am on Monday 29 September 2008 at the offices of Abchurch Communications Ltd, 5th Floor, 100 Cannon Street, London, EC4N 6EU.
- Ends -
For further information:
|
Surgical Innovations Group plc |
|
|
Graham Bowland, Managing Director |
Tel: +44 (0) 113 230 7597 |
|
www.sigroupplc.com |
|
Hanson Westhouse Limited |
|
|
Tim Feather / Matthew Johnson |
Tel: +44 (0) 113 246 2611 |
|
www.hansonwesthouse.com |
Media enquiries:
|
Abchurch Communications |
|
|
Sarah Hollins / Gareth Mead /Jack Ballantyne |
Tel: +44 (0) 20 7398 7714 |
|
www.abchurch-group.com |
Notes to Editors:
Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group employs over 50 people and is headquartered in Leeds.
The Group's subsidiaries Surgical Innovations Limited and Haemocell Limited are focused on strong international growth in two specialist areas namely minimally invasive surgery, where products are used in 'keyhole' surgery which is more accurately known as laparoscopic surgery, and products for autologous blood transfusion whereby a patient's own blood is recycled.
The Group's subsidiary company Core Precision Limited utilises Surgical Innovations' core medical device design expertise and technology in innovative engineering applications.
For more information, see www.sigroupplc.com
Related Shares:
Surgical Innovations